Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $93.50 | Total: $467.50 |
| 1 | 10 | $79.20 | Total: $792.00 |
| 1 | 25 | $67.10 | Total: $1,677.50 |
| 1 | 50 | $57.20 | Total: $2,860.00 |
| 1 | 100 | $49.50 | Total: $4,950.00 |
Overview
AZD8309 is a potent, orally available antagonist of the chemokine receptor CXCR2 that regulates neutrophil transport, significantly reduces MPO in the pancreas and lung, and decreases trypsin and elastase activity in the pancreas.AZD8309 can be used to study a range of inflammatory diseases.
Chemical Properties
| Molecular Formula | C15H14F2N4O2S2 |
| Molecular Weight | 384.42 |
| CAS Numbers | 333742-48-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N([C@@H](CO)C)C1=C2C(=NC(SCC3=C(F)C(F)=CC=C3)=N1)NC(=O)S2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Malla SR, et al. Effect of oral administration of AZD8309, a CXCR2 antagonist, on the severity of experimental pancreatitis. Pancreatology. 2016;16[5] 761-769.